Why The 29% Return On Capital At APT Medical (SHSE:688617) Should Have Your Attention
Why The 29% Return On Capital At APT Medical (SHSE:688617) Should Have Your Attention
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. With that in mind, the ROCE of APT Medical (SHSE:688617) looks great, so lets see what the trend can tell us.
你知道有一些财务指标可以提供潜在倍增的线索吗?其中,我们将希望看到两个方面;首先,资本雇用回报率(ROCE)的增长,其次,公司资本雇用的扩大。最终,这表明这是一个以递增的回报率重新投资利润的业务。考虑到这一点,APt Medical(上证交易所:688617)的ROCE看起来很不错,所以让我们看一下趋势能告诉我们什么。
Understanding Return On Capital Employed (ROCE)
上面您可以看到蒙托克可再生能源现行ROCE与之前资本回报的比较,但过去只能知道这么多。如果您感兴趣,可以查看我们免费的蒙托克可再生能源分析师报告,了解分析师的预测。
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for APT Medical, this is the formula:
对于那些不了解的人来说,ROCE是一个公司的年度税前利润(回报)相对于业务中所使用的资本的度量。要计算APt Medical的这个指标,使用以下公式:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
资产雇用回报率(ROCE)是指企业利润,即企业税前利润除以企业投入的总资本(负债加股权)。如果ROCE高于企业财务成本的承受能力,那么企业就会创造出更多的价值。
0.29 = CN¥634m ÷ (CN¥2.7b - CN¥541m) (Based on the trailing twelve months to June 2024).
0.29 = CN¥63400万 ÷ (CN¥27亿 - CN¥541m) (基于截至2024年6月的过去十二个月)
Thus, APT Medical has an ROCE of 29%. That's a fantastic return and not only that, it outpaces the average of 6.0% earned by companies in a similar industry.
因此,APt Medical的ROCE为29%。这是一个很棒的回报,而且不仅如此,它超过了同行业公司平均6.0%的回报。
In the above chart we have measured APT Medical's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for APT Medical .
在上图中,我们对APt Medical之前的ROCE进行了测量,但未来可能更重要。如果您想了解分析师对未来的预测,请查看我们为APt Medical准备的免费分析报告。
What The Trend Of ROCE Can Tell Us
尽管如此,当我们看 enphase energy (纳斯达克股票代码:ENPH) 的时候,它似乎并没有完全符合这些要求。
APT Medical is displaying some positive trends. Over the last five years, returns on capital employed have risen substantially to 29%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 499%. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.
APt Medical显示出一些积极的趋势。在过去五年中,资本利用率回报率大幅提高至29%。公司在每一美元的资本使用上实际赚得更多的钱,值得注意的是资本的金额也增加了499%。在日益增长的资本数量上获得日益增长的回报率,在多倍股中是常见的,这也是我们印象深刻的原因。
The Key Takeaway
重要提示
In summary, it's great to see that APT Medical can compound returns by consistently reinvesting capital at increasing rates of return, because these are some of the key ingredients of those highly sought after multi-baggers. Since the stock has returned a solid 54% to shareholders over the last three years, it's fair to say investors are beginning to recognize these changes. Therefore, we think it would be worth your time to check if these trends are going to continue.
总而言之,令人高兴的是,APt Medical能够通过持续以日益增加的回报率再投资资本来实现复利回报,因为这些是追求高收益的多倍股的关键因素之一。由于该股在过去三年中为股东带来了可观的54%回报,因此可以说投资者开始认识到这些变化。因此,我们认为值得您花时间检查这些趋势是否会继续。
If you want to continue researching APT Medical, you might be interested to know about the 1 warning sign that our analysis has discovered.
如果您想继续研究APt Medical,您可能会对我们的分析发现的1个风险警告感兴趣。
If you'd like to see other companies earning high returns, check out our free list of companies earning high returns with solid balance sheets here.
如果您想看到其他公司获得高回报,请在此查看我们免费的高回报、坚实财务状况的公司列表。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。